DEVA Holding A.Ş. is a Turkish pharmaceutical company founded in 1958. As of 2024, it ranked 3rd in unit sales (5.3%) and 6th in TL sales (2.9%) in Turkey’s pharmaceutical market.
| Type | Pharmaceutical Company |
|---|---|
| BİST: DEVA | |
| Industry | Pharmaceuticals |
| Founded | September 22, 1958 |
| Headquarters | Istanbul, Turkey |
Key people | Mr. Philipp Haas (Chairman and CEO) |
| Products | pharmaceuticals |
| Revenue | |
| Total assets | |
| Total equity | |
Number of employees | 3.000 |
| Website | www.deva.com.tr |
The company operates three EU GMP- and US FDA-approved facilities in Çerkezköy and Kartepe, with an annual production capacity of 620 million units. DEVA’s portfolio covers 10 therapeutic areas—including cardiovascular, dermatology, ophthalmology, hematology, and anti-infectives—and includes 1404 registered products across 82 countries.
DEVA employs over 500 researchers and 3,000 staff in total. According to Turkishtime’s 2024 R&D 250 Report, it is the Turkish pharmaceutical company with the largest amount of R&D expenditure.[1][2][3]
History
editDEVA Holding A.Ş. was founded in 1958, with an initial focus on the manufacturing of essential medicines for the domestic market. It is currently one of Turkey’s largest producers of generic pharmaceuticals.
By the 2000s, DEVA had become a global company, obtaining EU GMP and US FDA certifications and entering numerous export markets.[4][5]
References
edit- ↑ "Antibiotic Long Distance Run". Fortune Magazine. 19 July 2019. Archived from the original on 2019-09-05. Retrieved 15 September 2019.
- ↑ "5 Minutes Interview with: Philipp Haas - Deva". Pharma Horizon Magazine. 4 May 2017. Archived from the original on 2019-10-28. Retrieved 15 September 2019.
- ↑ "Philipp Haas – Chairman & CEO, DEVA, Turkey". Pharma Boardroom Magazine. 29 November 2018. Archived from the original on 2019-10-28. Retrieved 15 September 2019.
- ↑ "» 5 minutes interview with: Philipp Haas – DEVA". TKS Publisher. Retrieved 2019-10-28.
- ↑ "DEVA.IS - Deva Holding AS Profile | Reuters". www.reuters.com. Retrieved 2019-10-28.